PASSAGE BIO INC (PASG) Fundamental Analysis & Valuation

NASDAQ:PASG • US7027122099

Current stock price

8.08 USD
+0.23 (+2.93%)
Last:

This PASG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PASG Profitability Analysis

1.1 Basic Checks

  • In the past year PASG has reported negative net income.
  • In the past year PASG has reported a negative cash flow from operations.
  • PASG had negative earnings in each of the past 5 years.
  • In the past 5 years PASG always reported negative operating cash flow.
PASG Yearly Net Income VS EBIT VS OCF VS FCFPASG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • PASG's Return On Assets of -73.09% is on the low side compared to the rest of the industry. PASG is outperformed by 65.76% of its industry peers.
  • The Return On Equity of PASG (-242.72%) is worse than 71.76% of its industry peers.
Industry RankSector Rank
ROA -73.09%
ROE -242.72%
ROIC N/A
ROA(3y)-68.04%
ROA(5y)-62.45%
ROE(3y)-146.72%
ROE(5y)-113.18%
ROIC(3y)N/A
ROIC(5y)N/A
PASG Yearly ROA, ROE, ROICPASG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PASG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PASG Yearly Profit, Operating, Gross MarginsPASG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PASG Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PASG has more shares outstanding
  • Compared to 5 years ago, PASG has more shares outstanding
  • PASG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PASG Yearly Shares OutstandingPASG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M
PASG Yearly Total Debt VS Total AssetsPASG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • PASG has an Altman-Z score of -17.30. This is a bad value and indicates that PASG is not financially healthy and even has some risk of bankruptcy.
  • PASG has a Altman-Z score of -17.30. This is amonst the worse of the industry: PASG underperforms 82.01% of its industry peers.
  • There is no outstanding debt for PASG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.3
ROIC/WACCN/A
WACCN/A
PASG Yearly LT Debt VS Equity VS FCFPASG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.07 indicates that PASG has no problem at all paying its short term obligations.
  • PASG's Current ratio of 2.07 is on the low side compared to the rest of the industry. PASG is outperformed by 75.82% of its industry peers.
  • PASG has a Quick Ratio of 2.07. This indicates that PASG is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PASG (2.07) is worse than 73.69% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
PASG Yearly Current Assets VS Current LiabilitesPASG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PASG Growth Analysis

3.1 Past

  • PASG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.94%, which is quite impressive.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PASG will show a very strong growth in Earnings Per Share. The EPS will grow by 25.57% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y64.89%
EPS Next 2Y32.15%
EPS Next 3Y25.36%
EPS Next 5Y25.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PASG Yearly Revenue VS EstimatesPASG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
PASG Yearly EPS VS EstimatesPASG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. PASG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PASG. In the last year negative earnings were reported.
  • Also next year PASG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PASG Price Earnings VS Forward Price EarningsPASG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PASG Per share dataPASG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PASG's earnings are expected to grow with 25.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.15%
EPS Next 3Y25.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PASG Dividend Analysis

5.1 Amount

  • PASG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PASG Fundamentals: All Metrics, Ratios and Statistics

PASSAGE BIO INC

NASDAQ:PASG (4/2/2026, 8:00:02 PM)

8.08

+0.23 (+2.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners52.09%
Inst Owner Change0%
Ins Owners0.48%
Ins Owner Change0.08%
Market Cap25.94M
Revenue(TTM)N/A
Net Income(TTM)-45.52M
Analysts86.15
Price Target31.42 (288.86%)
Short Float %3.08%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.06%
Min EPS beat(2)-50.68%
Max EPS beat(2)14.57%
EPS beat(4)2
Avg EPS beat(4)-3.58%
Min EPS beat(4)-50.68%
Max EPS beat(4)28.35%
EPS beat(8)5
Avg EPS beat(8)-0.89%
EPS beat(12)7
Avg EPS beat(12)-0.04%
EPS beat(16)11
Avg EPS beat(16)4.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-22.22%
PT rev (3m)-22.22%
EPS NQ rev (1m)-50.75%
EPS NQ rev (3m)-50.75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)-14.35
EYN/A
EPS(NY)-5.04
Fwd EYN/A
FCF(TTM)-9.82
FCFYN/A
OCF(TTM)-9.82
OCFYN/A
SpS0
BVpS5.84
TBVpS5.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.09%
ROE -242.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-68.04%
ROA(5y)-62.45%
ROE(3y)-146.72%
ROE(5y)-113.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z -17.3
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.25%
EPS Next Y64.89%
EPS Next 2Y32.15%
EPS Next 3Y25.36%
EPS Next 5Y25.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-71.22%
EBIT Next 3Y30.9%
EBIT Next 5Y38.63%
FCF growth 1Y34.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.3%
OCF growth 3YN/A
OCF growth 5YN/A

PASSAGE BIO INC / PASG Fundamental Analysis FAQ

What is the fundamental rating for PASG stock?

ChartMill assigns a fundamental rating of 2 / 10 to PASG.


Can you provide the valuation status for PASSAGE BIO INC?

ChartMill assigns a valuation rating of 1 / 10 to PASSAGE BIO INC (PASG). This can be considered as Overvalued.


How profitable is PASSAGE BIO INC (PASG) stock?

PASSAGE BIO INC (PASG) has a profitability rating of 0 / 10.


What is the expected EPS growth for PASSAGE BIO INC (PASG) stock?

The Earnings per Share (EPS) of PASSAGE BIO INC (PASG) is expected to grow by 64.89% in the next year.